| Luís Costa, Hospital de Santa Maria, Lisbon, Portugal |
| Chair: Luís Costa, Hospital de Santa Maria, Lisbon, Portugal |
|
| 15:15 - 15:35 | Surgery after neoadjuvant treatment: How does clinical stage determine the options? Monica Morrow, Memorial Sloan Kettering Cancer Center, New York, USA |
| 15:35 - 15:55 | (Neo) Adjuvant medical treatment in triple-negative breast cancer Peter Schmid, Barts Breast Cancer Centre, London, UK |
| 15:55 - 16:05 | Local relapse: Time to revisit treatment options? Michael Gnant, Medical University of Vienna, Austria |
| 16:05 - 16:25 | Discussion |
| Chair: Miguel Abreu, Instituto Português de Oncologia do Porto, Portugal |
|
| 16:40 - 17:00 | Metastatic relapse during adjuvant hormonal treatment − Main options Hope Rugo, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA |
| 17:00 - 17:20 | ADCs in metastatic luminal breast cancer Aditya Bardia, Harvard Medical School, Boston, USA |
| 17:20 - 17:40 | Endocrine adjuvant therapy in pre-menopause Eva Ciruelos, Hospital 12 de Octubre, Madrid, Spain |
| 17:40 - 18:00 | Discussion |